A) A muscle abnormality. B) A type of blood cell. C) An abnormal growth of tissue in bone. D) A skin condition.
A) From the brain. B) From cancers in another part of the body such as lung, breast, thyroid, kidney, and prostate. C) From the liver. D) Only from the bone itself.
A) A dislocated shoulder. B) A broken rib. C) A pathologic fracture. D) A sprained ankle.
A) Hearing loss. B) Fatigue, fever, weight loss, anemia, and nausea. C) Coughing and sneezing. D) Blurred vision.
A) By blood pressure measurement. B) By X-ray and other radiological tests such as CT scan, MRI, PET scan, and bone scintigraphy. C) By urine color analysis. D) By a physical exam alone.
A) Complete blood count, inflammatory markers, serum electrophoresis, PSA, kidney function, and liver function. B) Cholesterol levels. C) Hemoglobin A1c. D) Blood sugar levels.
A) Protein levels. B) Bence Jones protein. C) Glucose. D) Urea.
A) A blood transfusion. B) A physical therapy session. C) A biopsy for histological evaluation. D) A dietary consultation.
A) Ewing sarcoma. B) Chondrosarcoma. C) Non-ossifying fibroma. D) Osteosarcoma.
A) 85%. B) 50%. C) 68%. D) 90%.
A) In a foot bone in South Africa. B) In a hand bone in Egypt. C) In a skull bone in China. D) In a rib bone in India.
A) Tumors that originate in the brain. B) Tumors that originate in the lungs. C) Tumors that originate in the liver. D) Tumors that originate in bone or from bone-derived cells and tissues.
A) Tumors that originate in other sites and spread to the skeleton. B) Tumors that originate in the heart. C) Tumors that originate in the skin. D) Tumors that originate in the kidneys.
A) Skin, brain, and ovaries. B) Stomach, colon, and bladder. C) Lungs, liver, and pancreas. D) Prostate, breasts, lungs, thyroid, and kidneys.
A) Ewing sarcoma. B) Chondrosarcoma. C) Osteosarcoma. D) Osteochondroma.
A) Benign tumor. B) Metastatic tumor. C) Hamartoma. D) Bone sarcoma.
A) Distal femur and proximal tibia. B) Spine and pelvis. C) Chest and abdomen. D) Shoulder and elbow.
A) Thrombocytopenia. B) Multiple myeloma. C) Leukemia. D) Lymphoma.
A) In the kidneys. B) In the liver. C) In the lungs. D) In the midline of the sacrum, coccyx, or both.
A) Using only physical exams. B) Using specialized studies like genetic and immunohistochemical tests. C) Using only X-rays. D) Using only blood tests.
A) Osteosarcoma B) Fibrosarcoma C) Chondrosarcoma D) Ewing sarcoma
A) Improved reflexes B) Neurological signs C) Increased muscle tone D) Enhanced coordination
A) They are rarely ever curable B) They are easily treated with medication C) They do not require diagnosis D) They are always benign
A) Intravenous chemotherapy B) Intra-arterial protocol with serial arteriogram C) Topical chemotherapy D) Oral chemotherapy
A) When tumor response has reached >90% necrosis B) Immediately after chemotherapy starts C) When tumor response is <50% necrosis D) After 6 months of treatment
A) Strontium-89 chloride B) Radiotherapy C) Chemotherapy drugs D) Non-hormonal bisphosphonates
A) Radiotherapy B) Chemotherapy C) Joint preservation surgical reconstruction D) Limb amputation
A) Surgical resection B) Pain medication C) External beam radiation therapy D) Chemotherapy
A) The outcome is generally good. B) The outcome is uncertain. C) The outcome is always fatal. D) The outcome is poor.
A) Yes, some types may eventually become malignant. B) No, they remain benign forever. C) Yes, all benign tumors become cancerous. D) No, they never become cancerous.
A) Cure is impossible. B) All patients are cured. C) Most patients achieve a cure, but it depends on various factors. D) Cure rate is independent of tumor type, location, and size.
A) Around 0.2%. B) Around 50%. C) Around 5%. D) Around 10%. |